CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region

Clinical Endocrinology

Volumn 53, Issue 1, 2000, Pages 117-125

  Balsamo, Antonio ^a,b   Cacciari, Emanuele ^a,b   Baldazzi, Lilia ^a,b   Tartaglia, Lucia ^a,b   Cassio, Alessandra ^a,b   Mantovani, Vilma ^a,b   Piazzi, Sandro ^a,b   Cicognani, Alessandro ^a,b   Pirazzoli, Piero ^a,b   Mainetti, Benedetta ^a,b   Zappulla, Franco ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HYDROXYPROGESTERONE;

ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GENE CONVERSION; GENE DELETION; GENE LOCUS; GENETIC EPIDEMIOLOGY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PHENOTYPE; PRIORITY JOURNAL;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HLA-B ANTIGENS; HLA-DR ANTIGENS; HUMANS; MALE; MUTATION; NEONATAL SCREENING; PHENOTYPE; RETROSPECTIVE STUDIES; STEROID 21-HYDROXYLASE;

EID: 0033846590     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01048.x     Document Type: Article

References (37)

1. Molecular genotyping in Brasilian patients with classical and non classical forms of 21-hydroxylase deficiency
2. Two mutations causing complete androgen insensitivity: A frame-shift in the steroid binding domain and a Cys-Phe substitution in the second zinc finger of the androgen receptor
3. Congenital adrenal hyperplasia: Neonatal mass screening compared to clinical diagnosis only in the Emilia-Romagna Region of Italy (1980-95)
4. Genetic population structure of Italy. II. Physical and cultural barriers to gene flow
5. Neonatal Screening for congenital adrenal hyperplasia
6. Molecular characterization of 21-hydroxylase deficiency in 70 Italian patients
7. A missense mutation at Ile172-Asn or Arg356-Trp causes steroid 21-hydroxylase deficiency
8. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population
9. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia
10. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene
11. Aberrant splicing and missense mutations cause steroid 21-hydroxylase [P-450 (C21)] deficiency in humans: Possible gene conversion products
12. Effects of individual mutations in the P-450 (C21) pseudogene on the P450 (C21) activity and their distribution in the patient genomes of congenital steroid 21-hydroxylase deficiency
13. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population
14. The human gene mutation database
15. A cluster of missense mutation at Arg356 of human steroid 21-hydroxylase may impair redox partner interaction
16. Rearrangments and five mutations of P450c21 genes are distinguished by 5 restriction endonuclease haplotypes identified by a new probing strategy in 57 families with congenital adrenal hyperplasia
17. Distribution of deletions and seven poit mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency
18. Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability
19. Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency
20. Molecular genetic analysis of patients carrying steroid 21-hydroxylase deficiency in the Mexican population: Identification of possible new mutations and high prevalence of apparent germ-line mutations
21. CAH due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
22. Vollkommen manliche auere genitaletwiklung und salzverlustsyndrom bei madchen mit kongenitalemadrenogenitalem syndrom
23. Editorial: Neonatal screening for 21-hydroxylase deficient congenital adrenal hyperplasia - The role of CYP21 analysis
24. Alternate promoters and alternate splicing of human tenascin-X, a gene with 5' and 3' ends buried in others genes
25. High frequency of nonclassic steroid 21-hydroxylase deficiency
26. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
27. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
28. Molecular analysis of patients and carriers genes with congenital steroid 21-hydroxylase deficiency by using polymerase chain reaction and single strand conformational polymorphism
29. De novo mutation cause steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings
30. Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan
31. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia
32. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus
33. A mutation (Pro30 to Leu) in CYP21 represents a potential non classic steroid 21-hydroxylase deficiency that are not apparent gene conversions
34. Low frequency of deletion alleles in patients with steroid 21-hydroxylase deficiency in a Mexican population
35. Mutational Spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
36. Structure of the human 21-hydroxylase genes
37. Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Va1281, and Ser268 result in complete, partial or no loss of enzymatic activity, respectively